Tesamorelin (CAS 218949-48-5) – Growth Hormone Secretagogue API

Tesamorelin (CAS 218949-48-5) is a high-purity synthetic growth hormone-releasing hormone (GHRH) analog API, engineered to stimulate the pituitary gland to secrete endogenous growth hormone (GH) in a pulsatile, physiological pattern. Its modified amino acid sequence enhances stability and receptor affinity, delivering sustained efficacy with minimal adverse effects compared to native GHRH. Produced via advanced solid-phase peptide synthesis and GMP-compliant processes, it ensures ultra-high purity, consistent bioactivity, and compliance with international peptide pharmaceutical standards.

This premium API is a core raw material for pharmaceutical manufacturers developing therapies for HIV-associated lipodystrophy and growth hormone deficiency. It is widely applied in formulating injectable medications targeting visceral fat reduction, body composition optimization, and metabolic function improvement. With proven clinical efficacy and favorable safety profiles, it addresses the unmet medical needs of specific patient populations. For R&D teams and production enterprises, it provides a trusted solution to advance endocrinology and metabolic disorder treatment development.